Search

Author/Creator Lawrence, Donald

1. 228 Radiological dynamics and resistance types in patients with advanced melanoma treated with anti-PD-1 monotherapy. (9th November 2020)

Authors:
Bai, Xue; Kim, Michelle; Kasumova, Gyulnara; Si, Lu; Tang, Bixia; Cui, Chuanliang; Yang, Xiaoling; Wei, Xiaoting; Cohen, Justine; Lawrence, Donald; Freedman, Christine; Fadden, Riley; Rubin, Krista; Sharova, Tatyana; Frederick, Dennie; Flaherty, Keith; Sullivan, Ryan; Guo, Jun; Boland, Genevieve
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A136
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 228 Radiological dynamics and resistance types in patients with advanced melanoma treated with anti-PD-1 monotherapy. (9th November 2020)

Authors:
Bai, Xue; Kim, Michelle; Kasumova, Gyulnara; Si, Lu; Tang, Bixia; Cui, Chuanliang; Yang, Xiaoling; Wei, Xiaoting; Cohen, Justine; Lawrence, Donald; Freedman, Christine; Fadden, Riley; Rubin, Krista; Sharova, Tatyana; Frederick, Dennie; Flaherty, Keith; Sullivan, Ryan; Guo, Jun; Boland, Genevieve
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A246
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. 312 Female sex independently predicts adjuvant immunotherapeutic benefit from CTLA4 immune checkpoint inhibition. (9th November 2020)

Authors:
Tarhini, Ahmad; Kang, Ni; Lee, Sandra; Stephen Hodi, F; Cohen, Gary; Hamid, Omid; Hutchins, Laura; Sosman, Jeffrey; Kluger, Harriett; Eroglu, Zeynep; Koon, Henry; Lawrence, Donald; Kendra, Kari; Minor, David; Lee, Carrie; Albertini, Mark; Flaherty, Lawrence; Petrella, Teresa; Striecher, Howard; S...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A339
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. A first‐in‐human phase I, multicenter, open‐label, dose‐escalation study of the oral RAF/VEGFR‐2 inhibitor (RAF265) in locally advanced or metastatic melanoma independent from BRAF mutation status. (18th July 2017)

Authors:
Izar, Benjamin; Sharfman, William; Hodi, F. Stephen; Lawrence, Donald; Flaherty, Keith T.; Amaravadi, Ravi; Kim, Kevin B.; Puzanov, Igor; Sosman, Jeffrey; Dummer, Reinhard; Goldinger, Simone M.; Lam, Lyhping; Kakar, Shefali; Tang, Zhongwen; Krieter, Oliver; McDermott, David F.; Atkins, Michael B.
Journal:
Cancer medicine
Issue:
Volume 6:Number 8(2017:Aug.)
Page Start:
1904
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Clinical experience with combination BRAF/MEK inhibitors for melanoma with brain metastases: a real-life multicenter study. Issue 1 (February 2019)

Authors:
Drago, Joshua Z.; Lawrence, Donald; Livingstone, Elisabeth; Zimmer, Lisa; Chen, Tianqi; Giobbie-Hurder, Anita; Amann, Valerie C.; Mangana, Joanna; Siano, Marco; Zippelius, Alfred; Dummer, Reinhard; Goldinger, Simone M.; Sullivan, Ryan J.
Journal:
Melanoma research
Issue:
Volume 29:Issue 1(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. CMET-16. THE ROLE OF SURGICAL RESECTION OF MELANOMA BRAIN METASTASES IN THE IMMUNOTHERAPY ERA. (5th November 2018)

Authors:
Alvarez-Breckenridge, Christopher; Giobbie-Hurder, Anita; Gill, Corey; Bertalan, Mia; Stocking, Jackson; Kaplan, Alexander; Nayyar, Naema; Lawrence, Donald; Flaherty, Keith; Shih, Helen; Oh, Kevin; Batchelor, Tracy; Cahill, Daniel; Sullivan, Ryan; Brastianos, Priscilla
Journal:
Neuro-oncology
Issue:
Volume 20(2018)Supplement 6
Page Start:
vi56
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. CMET-20. EVIDENCE OF CNS RESPONSE OF PEMBROLIZUMAB FOR LEPTOMENINGEAL CARCINOMATOSIS AT A SINGLE CELL RESOLUTION. (5th November 2018)

Authors:
Alvarez-Breckenridge, Christopher; Prakadan, Sanjay; Lee, Eudocia; Tolaney, Sara; Nayak, Lakshmi; Lin, Nancy; Bihun, Ivanna; Chukwueke, Ugonma; Oh, Kevin; White, Michael; Gerstner, Elizabeth; Lawrence, Donald; Cohen, Justine; Giobbie-Hurder, Anita; Cahill, Daniel; Carter, Scott; Shalek, Alex; Sul...
Journal:
Neuro-oncology
Issue:
Volume 20(2018)Supplement 6
Page Start:
vi57
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. CMET-33. PHASE II STUDY OF PALBOCICLIB IN BRAIN METASTASES HARBORING CDK PATHWAY ALTERATIONS. (11th November 2019)

Authors:
Brastianos, Priscilla; Cohen, Justine; Wang, Nancy; Lee, Eudocia; Ligibel, Jennifer; Chukwueke, Ugonma; Keeley, Maura; Oh, Kevin; White, Michael; Gerstner, Elizabeth; Batchelor, Tracy; Lawrence, Donald; Ryan, David P; John Iafrate, A; Giobbie-Hurder, Anita; Flaherty, Keith; Santagata, Sandro; Car...
Journal:
Neuro-oncology
Issue:
Volume 21(2019)Supplement 6
Page Start:
vi58
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. High‐dose glucocorticoids for the treatment of ipilimumab‐induced hypophysitis is associated with reduced survival in patients with melanoma. Issue 18 (5th July 2018)

Authors:
Faje, Alexander T.; Lawrence, Donald; Flaherty, Keith; Freedman, Christine; Fadden, Riley; Rubin, Krista; Cohen, Justine; Sullivan, Ryan J.
Journal:
Cancer
Issue:
Volume 124:Issue 18(2018)
Page Start:
3706
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Hypophysitis secondary to nivolumab and pembrolizumab is a clinical entity distinct from ipilimumab-associated hypophysitis. Issue 3 (September 2019)

Authors:
Faje, Alexander; Reynolds, Kerry; Zubiri, Leyre; Lawrence, Donald; Cohen, Justine V; Sullivan, Ryan J; Nachtigall, Lisa; Tritos, Nicholas
Journal:
European journal of endocrinology
Issue:
Volume 181:Issue 3(2019)
Page Start:
211
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗